Security Name | Ticker | % of Net Assets |
---|---|---|
ELI LILLY & COMPANY | LLY | 4.32% |
UNITEDHEALTH GROUP INC. | UNH | 3.24% |
JOHNSON & JOHNSON | JNJ | 2.87% |
MERCK & COMPANY, INC. | MRK | 2.79% |
ABBVIE INC | ABBV | 2.66% |
THERMO FISHER SCIENTIFIC | TMO | 2.18% |
ABBOTT LABORATORIES | ABT | 2.07% |
AMGEN INC. | AMGN | 2.04% |
DANAHER CORPORATION | DHR | 2.02% |
INTUITIVE SURGICAL, INC. | ISRG | 1.97% |
PFIZER INC | PFE | 1.93% |
ELEVANCE HEALTH INC | ANTM | 1.72% |
VERTEX PHARMACEUTICALS | VRTX | 1.66% |
STRYKER CORP | SYK | 1.66% |
REGENERON PHARMACEUTICALS | REGN | 1.64% |
BOSTON SCIENTIFIC CORP | BSX | 1.63% |
THE CIGNA GROUP | CI | 1.50% |
GILEAD SCIENCES, INC. | GILD | 1.47% |
BRISTOL MYERS SQUIBB CO | BMY | 1.42% |
ZOETIS INC | ZTS | 1.35% |
MCKESSON CORPORATION | MCK | 1.33% |
ASTRAZENECA PLC ADR | AZN | 1.32% |
CVS HEALTH CORP. | CVS | 1.29% |
BECTON DICKINSON & CO | BDX | 1.26% |
HCA HEALTCARE INC | HCA | 1.25% |
EDWARDS LIFESCIENCES CORP | EW | 1.18% |
MEDTRONIC PLC | MDT | 1.17% |
ALNYLAM PHARMACEUTICALS | ALNY | 1.05% |
DEXCOM INC | DXCM | 1.04% |
NOVO-NORDISK A/S -ADR | NVO | 1.04% |
HUMANA, INC. | HUM | 1.02% |
IDEXX LABORATORIES INC | IDXX | 0.98% |
ICON PLC | ICLR | 0.95% |
CENCORA INC | ABC | 0.95% |
AGILENT TECHNOLOGIES, INC | A | 0.95% |
IQVIA HOLDINGS INC | IQV | 0.94% |
ARGENX SE - ADR | ARGX | 0.92% |
CENTENE CORP | CNC | 0.92% |
GE HEALTHCARE TECHNOLOGY | GEHC | 0.90% |
MODERNA INC | MRNA | 0.89% |
BIOGEN IDEC, INC. | BIIB | 0.87% |
METTLER-TOLEDO INTERNATIO | MTD | 0.82% |
ALKERMES PLC | ALKS | 0.81% |
NOVARTIS ADR | NVS | 0.81% |
VEEVA SYSTEMS-A | VEEV | 0.79% |
RESMED INC | RMD | 0.77% |
CARDINAL HEALTH, INC. | CAH | 0.76% |
GSK PLC-SPON ADR | GSK-W | 0.75% |
WEST PHARMACEUTICAL SERVI | WST | 0.74% |
TEVA PHARMACEUTICAL | TEVA | 0.73% |
ZIMMER BIOMET HOLDINGS IN | ZBH | 0.73% |
CRISPR THERAPEUTICS AG | CRSP | 0.68% |
LABCORP HOLDINGS INC | LH | 0.65% |
HOLOGIC, INC. | HOLX | 0.64% |
MOLINA HEALTHCARE INC | MOH | 0.64% |
SAREPTA THERAPEU | SRPT | 0.64% |
BAXTER INTERNATIONAL | BAX | 0.64% |
WATERS CORPORATION | WAT | 0.63% |
ILLUMINA INC | ILMN | 0.62% |
COOPER COS INC/THE | COO | 0.62% |
BIOMARIN PHARMACEUTICAL | BMRN | 0.61% |
ALIGN TECHNOLOGY | ALGN | 0.60% |
QUEST DIAGNOSTICS, INC. | DGX | 0.60% |
UNITED THERAPEUTICS CORP | UTHR | 0.59% |
INSULET CORP | PODD | 0.59% |
AVANTOR INC | AVTR | 0.58% |
ROYALTY PHARMA PLC- CL A | RPRX | 0.56% |
TENET HEALTHCARE CORP | THC | 0.55% |
NEUROCRINE BIOSCIENCES IN | NBIX | 0.55% |
NATERA INC | NTRA | 0.54% |
UNIVERSAL HEALTH SERVICES | UHS | 0.54% |
VIATRIS INC | VTRS | 0.54% |
INCYTE CORP | INCY | 0.52% |
BIO-TECHNE CORP | TECH | 0.50% |
CATALENT INC | CTLT | 0.48% |
MEDPACE HOLDINGS | MEDP | 0.47% |
EXACT SCIENCES | EXAS | 0.45% |
HENRY SCHEIN, INC. | HSIC | 0.43% |
VAXCYTE INC | PCVX | 0.43% |
HEALTHEQUITY INC | HQY | 0.42% |
INTRA-CELLULAR T | ITCI | 0.41% |
REPLIGEN CORP | RGEN | 0.41% |
IONIS PHARMACEUTICALS, IN | IONS | 0.40% |
HALOZYME THERAPEUTICS INC | HALO | 0.40% |
DAVITA, INC | DVA | 0.40% |
BRUKER CORP | BRKR | 0.39% |
EXELIXIS, INC. | EXEL | 0.39% |
MASIMO CORP | MASI | 0.39% |
ACADIA HEALTHCAR | ACHC | 0.39% |
PENUMBRA INC | PEN | 0.38% |
CYTOKINETICS INC | CYTK | 0.38% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 0.38% |
REVOLUTION MEDICINES INC | RVMD | 0.37% |
LANTHEUS HOLDING | LNTH | 0.36% |
VIKING THERAPEUTICS INC | VKTX | 0.34% |
DENTSPLY SIRONA, NC. | XRAY | 0.34% |
ROIVANT SCIENCES LTD | ROIV | 0.34% |
OPTION CARE HEALTH INC | OPCH | 0.34% |
BLUEPRINT MEDICI | BPMC | 0.33% |
APELLIS PHARMACE | APLS | 0.31% |
AXSOME THERAPEUT | AXSM | 0.29% |
GUARDANT HEALTH INC | GH | 0.27% |
ULTRAGENYX PHARM | RARE | 0.27% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.27% |
BRIDGEBIO PHARMA INC | BBIO | 0.27% |
AZENTA INC | BRKS | 0.25% |
TG THERAPEUTICS | TGTX | 0.25% |
INARI MEDICAL INC | NARI | 0.24% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.22% |
MADRIGAL PHARMAC | MDGL | 0.22% |
R1 RCM INC | RCM | 0.22% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.22% |
INSPIRE MEDICAL SYSTEMS I | INSP | 0.20% |
TELADOC HEALTH INC | TDOC | 0.20% |
GRAIL INC | GRAL | 0.01% |
Other (Cash, derivatives and other liabilities) | 0.77% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.